Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$949K Buy
9,926
+656
+7% +$59.9K 0.09% 173
2026
Q1
$777K Sell
9,270
-602
-6% -$68K 0.08% 184
2025
Q4
$1.04M Sell
9,872
-2,071
-17% -$264K 0.12% 135
2025
Q3
$1.49M Buy
11,943
+1,331
+13% +$175K 0.14% 104
2025
Q2
$1.41M Buy
10,612
+2,503
+31% +$330K 0.11% 148
2025
Q1
$1.06M Buy
8,109
+6,327
+355% +$805K 0.1% 161
2024
Q4
$202K Buy
+1,782
New +$206K 0.02% 346

Other funds holding ABT

Armis Advisers's ABT Position: Q2 2026 in Review

Armis Advisers increased its Abbott (ABT) stake by 7.1% in Q2 2026, buying an estimated $59.9K and bringing the position to 9,926 shares worth $949K. The position accounts for 0.09% of the portfolio, ranked #173.

Armis Advisers first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.49M in Q3 2025. 610 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Armis Advisers held 9,926 shares of Abbott worth $949K as of Q2 2026.
  • Armis Advisers bought 656 Abbott shares in Q2 2026, an estimated $59.9K.
  • Abbott made up 0.09% of Armis Advisers's portfolio in Q2 2026, its #173 holding.
  • Armis Advisers first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Armis Advisers's Abbott position peaked at $1.49M in Q3 2025.
  • 610 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.